TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
VCYT

Veracyte Inc

Healthcare · Diagnostics & Research

45.40$ -6.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,486 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VCYT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,125 1,115 1,200 1,234 1,275 1,300 1,315 1,344 1,368 1,406 1,436 1,486
271 286 290 321 357 372 383 415 449 488 522 575
202 216 209 236 274 239 186 219 316 363 263 300
202 216 209 236 274 289 287 321 366 413 439 485
39 40 47 50 49 47 54 51 48 45 50 54
16 16 18 19 20 22 24 25 20 21 21 23
693 703 754 752 762 746 754 773 767 767 767 767
124 89 116 113 109 102 99 96 92 89 86 83
71 71 81 102 99 124 120 123 110 96 92 98
57 61 58 72 70 79 75 76 72 60 56 63
5.0 5.1 6.0 7.2 7.3 7.5 7.4 6.4 4.3 4.1 4.3 5.8
13 13 12 12 9.7 8.6 16 11 5.5 4.6 6.9 8.0
1,054 1,044 1,119 1,133 1,176 1,176 1,195 1,221 1,258 1,310 1,344 1,388
-440 -468 -470 -464 -449 -444 -437 -438 -419 -378 -349 -323
73 73 75 77 78 80 80 80 80 81 81 82

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?